What autoantibodies tell us about the pathogenesis of Parkinson's disease
- 6 June 2018
- journal article
- editorial
- Published by Wiley in Journal of Neurochemistry
- Vol. 145 (6) , 433-435
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Vaccination strategies in tauopathies and synucleinopathiesJournal of Neurochemistry, 2017
- Immunochemical Detection of α-Synuclein Autoantibodies in Parkinson’s Disease: Correlation between Plasma and Cerebrospinal Fluid LevelsACS Chemical Neuroscience, 2017
- The antibody aducanumab reduces Aβ plaques in Alzheimer’s diseaseNature, 2016
- ɑ‐Synuclein strains and the variable pathologies of synucleinopathiesJournal of Neurochemistry, 2016
- Sorting out release, uptake and processing of alpha‐synuclein during prion‐like spread of pathologyJournal of Neurochemistry, 2015
- Structure, function and toxicity of alpha‐synuclein: the Bermuda triangle in synucleinopathiesJournal of Neurochemistry, 2015
- Naturally Occurring Autoantibodies Against β-Amyloid2012
- The synaptic pathology of α-synuclein aggregation in dementia with Lewy bodies, Parkinson’s disease and Parkinson’s disease dementiaActa Neuropathologica, 2010
- Effects of α-Synuclein Immunization in a Mouse Model of Parkinson’s DiseaseNeuron, 2005
- Reduced levels of amyloid β-peptide antibody in Alzheimer diseaseNeurology, 2001